Literature DB >> 8287070

Expression and subcellular locations of two forms of nucleolar protein B23 in rat tissues and cells.

D Wang1, H Umekawa, M O Olson.   

Abstract

Protein B23 (Mr/pI = 38,000/5.1) is a major RNA-associated nucleolar phosphoprotein and putative ribosome assembly factor. Previous cDNA and genomic analyses indicated the presence of two forms of the protein (B23.1 and B23.2) which arise from a single gene via alternative splicing. Expression of the two B23 isoforms in rat tissues cells has been studied at the mRNA level using northern blot and RNA-polymerase chain reaction analyses and at the protein level by western blotting. In all tissues examined, the relative amount of B23.1 mRNA was much higher (3-6-fold) than B23.2 mRNA. For B23.1, the level of mRNA and protein expression was highest in Novikoff hepatoma cells, followed by testis, liver, and kidney. This suggests that B23.1 expression is correlated with the rate of proliferation of the tissue and/or the rate of ribosome biogenesis. In contrast, the amount of B23.2 mRNA did not vary significantly among the three normal tissues, although it was elevated in Novikoff hepatoma cells. Similarly, the B23.2 protein was barely detectable in the normal rat tissues, but significant quantities were found in the Novikoff cells. In cell fractionation experiments, B23.1 was predominantly found in nucleoli, whereas B23.2 was located in cytoplasmic fractions and appeared to be associated with cytoskeletal elements. These studies suggest that the two protein B23 isoforms are engaged in very different functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287070

Source DB:  PubMed          Journal:  Cell Mol Biol Res        ISSN: 0968-8773


  20 in total

Review 1.  Nucleophosmin and human cancer.

Authors:  Mi Jung Lim; Xin Wei Wang
Journal:  Cancer Detect Prev       Date:  2006-11-17

2.  Two splice variants of Nopp140 in Drosophila melanogaster.

Authors:  John M Waggener; Patrick J DiMario
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

3.  The ribonuclease activity of nucleolar protein B23.

Authors:  J E Herrera; R Savkur; M O Olson
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

4.  An extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancer.

Authors:  Piia-Riitta Karhemo; Antti Rivinoja; Johan Lundin; Maija Hyvönen; Anastasiya Chernenko; Johanna Lammi; Harri Sihto; Mikael Lundin; Päivi Heikkilä; Heikki Joensuu; Petri Bono; Pirjo Laakkonen
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

5.  Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1.

Authors:  Hideyo Ugai; George C Dobbins; Minghui Wang; Long P Le; David A Matthews; David T Curiel
Journal:  Virology       Date:  2012-06-18       Impact factor: 3.616

6.  Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions.

Authors:  Joyce M Bevington; Patrick G Needham; Kristin C Verrill; Roy F Collaco; Venkatesh Basrur; James P Trempe
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

7.  The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update.

Authors:  Raymond Lai; Robert J Ingham
Journal:  Ther Adv Hematol       Date:  2013-04

8.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.

Authors:  Mikael S Lindström
Journal:  Biochem Res Int       Date:  2010-10-05

9.  The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype.

Authors:  Mitsuru Okuwaki; Masafumi Tsujimoto; Kyosuke Nagata
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

10.  Relationship between adenovirus DNA replication proteins and nucleolar proteins B23.1 and B23.2.

Authors:  Clemence E Hindley; Andrew D Davidson; David A Matthews
Journal:  J Gen Virol       Date:  2007-12       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.